You are here: Industry Insights > GlobalData

News List

Rheumatoid Arthritis accounts for 18.9% share of global Immunology clinical trial activity in 2020 pharmaceutical-technology
June 17, 2021
Rheumatoid Arthritis accounted for an 18.9% share of the global clinical trials within the Immunology therapy area in 2020, registering a decrease of 4.4% when compared with the last ten-year average of 23.3% share, according to GlobalData.
Recent patent reforms will bolster innovative pharma research in China: GlobalData expresspharma
June 17, 2021
The highlights of the latest reforms are the drug patent linkage system, introduction of patent term extension for drugs and the patent term compensation system.
Global oncology Phase II clinical trials get disrupted by COVID-19: GlobalData expresspharma
June 15, 2021
Slow enrollment was the top reason, followed by enrollment suspension and lastly delayed initiation.
Clinical trials of COVID-19 vaccines and therapeutics demonstrate diverse trends: GlobalData expresspharma
June 11, 2021
The upward trend for vaccine COVID-19 clinical trials is expected to continue while there will be a decrease in therapeutic COVID-19 clinical trials.
Diagnosed prevalent cases of systemic sclerosis in 7MM to reach 187,000 by 2030: GlobalData expresspharma
June 04, 2021
The US will have the highest number of diagnosed prevalent cases of systemic sclerosis in the 7MM at 114,000.
Key unmet needs in HNSCC may be partly addressed by clinical development in next decade: GlobalData expresspharma
June 02, 2021
The next decade may see the introduction of personalised therapy options in locally advanced HNSCC settings along with identification of new druggable targets.
Neuropathic pain market to reach $25.2 billon by 2027: GlobalData expresspharma
May 31, 2021
The neuropathic pain market is the most valuable segment within the pain indications and was valued at $10.8 billion in 2020 globally. It is forecast to reach $25.2 billion by 2027 at a compound annual growth rate (CAGR) of 12.9 per cent.
Bio/pharma industry strives to solve shortage of viral vector used in many COVID-19 vaccines: GlobalData expresspharma
May 25, 2021
Viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities.
Novartis, Cadila Healthcare lead digital marketing space for ankylosing spondylitis in India: GlobalData expresspharma
May 21, 2021
Novartis and Cadila Healthcare are the only companies to offer support to AS patients through digital channels, finds GlobalData.
Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData expresspharma
May 20, 2021
The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to continue increasing in the foreseeable future.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 14 15 Next page